Home
Conditions
Lymphoma, Extranodal NK-T-Cell

Clinical trial condition

Lymphoma, Extranodal NK-T-Cell

Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.

157 public trials 17 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Extranodal NK-T-Cell trial results

Not Yet Recruiting

Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma

NCT05700448

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma

NCT07554482

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Beijing Tongren Hospital, Capital Medical University Beijing, China

View Trial Details

Not Yet Recruiting

Sintilimab, Chidamide, and Azacitidine for Untreated Stage I-II Extranodal NK/T-Cell Lymphoma

NCT07542912

Conditions: Adverse Event, Complete Remission Rate， CRR, Duration of Response, +8 more
Locations: Sun Yat-sen University Cancer Center Guangzhou, China

View Trial Details

Not Yet Recruiting

Phaes Ⅱ Study of Golidocitinib-Pegaspargase-PD-1 Antibody First-Line for Advanced ENKTL

NCT07457177

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Golidocitinib Combined With P-GemOx Plus PD-1 Inhibitor Versus P-GemOx Plus PD-1 Inhibitor in First-Line Newly Diagnosed Advanced or Non-Nasal Extranodal NK/T-Cell Lymphoma

NCT07385989

Conditions: Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Preconditioning With a Combination of Thiotepa, Cyclophosphamide, and Busulfan for Allogeneic Hematopoietic Stem Cell Transplantation in the Treatment of NK/T-Cell Lymphoma

NCT07276737

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

Clinical Study on Maintenance Therapy With Selinexor Combined With Azacitidine After Allogeneic Hematopoietic Stem Cell Transplantation for NK/T-cell Lymphoma

NCT07276698

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

A Study Comparing of P-GEMD Regimen Versus P-Gemox Regimen With Untreated Early-Stage NUAT or Advanced-Stage ENKTL.

NCT06953739

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Not specified

View Trial Details

Not Yet Recruiting

The Value of PET Imaging Targeting Granzyme B in Predicting Efficacy and Prognosis in T-NK Cell Lymphoma

NCT06863441

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Lipid Metabolism Disorders, +16 more
Locations: Ruijin Hospital Affiliated to Shanghai Jiao Tong University Medical School, Shanghai Shanghai, Shanghai Municipality, China

View Trial Details

Not Yet Recruiting

The Value of Artificial Intelligence-based 18F-FDG PET/CT in Diferential Diagnosis, Efficacy Prediction and Prognosis Prediction of T-NK Cell Lymphoma: a Clinical Study

NCT06747299

Conditions: Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
Locations: Ruijin Hospital affiliated to Shanghai Jiao Tong University of Medicine Shanghai, Shanghai Municipality, China

View Trial Details

Lymphoma, Extranodal NK-T-Cell

Lymphoma, Extranodal NK-T-Cell trial results

Related conditions